Form 8-K - Current report:
SEC Accession No. 0001193125-24-241114
Filing Date
2024-10-22
Accepted
2024-10-22 16:53:54
Documents
19
Period of Report
2024-10-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d890731d8k.htm   iXBRL 8-K 30839
2 EX-99.1 d890731dex991.htm EX-99.1 32529
7 GRAPHIC g890731g1022095122232.jpg GRAPHIC 7806
8 GRAPHIC g890731g44g05.jpg GRAPHIC 6323
9 GRAPHIC g890731g65c73.jpg GRAPHIC 3843
10 GRAPHIC g890731g87d17.jpg GRAPHIC 4409
  Complete submission text file 0001193125-24-241114.txt   265324

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20241022.xsd EX-101.SCH 3101
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20241022_def.xml EX-101.DEF 13867
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20241022_lab.xml EX-101.LAB 22898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20241022_pre.xml EX-101.PRE 14705
21 EXTRACTED XBRL INSTANCE DOCUMENT d890731d8k_htm.xml XML 5886
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 241386851
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)